In this analysis, 214 U.S. patients received the recently approved RYBREVANT FASPRO plus LAZCLUZE regimen with prophylactic strategies to reduce the risk of blood clots with oral anticoagulation and ...
HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...
Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab ...
Terminology shifts to “decompensated heart failure,” introducing an initial–stabilization–pre/postdischarge framework and ...
Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically ...
Despite notable advancements in the acute and long-term management, coronary artery disease and myocardial infarction (MI) ...
Early, consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent ...
Early and consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent ...
Since the publication of the 2015 American Heart Association scientific statement on infective endocarditis, its incidence ...
BBC News presenter Maryam Moshiri reveals her battle with polycythaemia vera, a rare blood cancer. Despite its incurability, ...
Maryam Moshiri reveals she has incurable blood cancer and explains why she decided to share her diagnosis after two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results